Rx-to-OTC switches sales will expand through 2036, with retail sales channels at 78.6% of sales channel sales in 2026. The market was valued at USD 43.4 billion in 2025, is projected to reach USD 71.7 billion by 2036 and is forecast to record a 4.7% CAGR between 2026 and 2036.